Onconova Therapeutics
- Pharmaceutical Preparations
- Newtown, Pennsylvania
Compensation history
Top executives at Onconova Therapeutics received an average of $1M per person in annual compensation from 2013 to 2023.
Average pay of disclosed executives at Onconova Therapeutics
By year
Executives
We found eight executives who work or worked at Onconova Therapeutics.
Steven Fruchtman
Onconova Therapeutics
Chief Executive Officer
Mark Guerin
Onconova Therapeutics
Chief Financial Officer
Victor Moyo
Onconova Therapeutics
Chief Medical Officer
Mark Gelder
Onconova Therapeutics
Chief Medical Officer
Abraham Oler
Onconova Therapeutics
General Counsel
Ramesh Kumar
Onconova Therapeutics
Chief Executive Officer
Manoj Maniar
Onconova Therapeutics
Senior Vice President, Product Development
Thomas McKearn
Onconova Therapeutics
President of Research and Development
News
Onconova Therapeutics CEO Steven Fruchtman's 2023 pay slips 17% to $1.1M
October 11, 2024
Onconova Therapeutics CEO Steven Fruchtman's 2022 pay falls 50% to $1.3M
June 7, 2023
Onconova Therapeutics CEO Steven Fruchtman's 2021 pay jumps 159% to $2.7M
May 25, 2022
Onconova Therapeutics CEO Ramesh Kumar's 2018 pay jumps 82% to $1.2M
April 29, 2019
About Onconova Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address12 Penns Trail, Newtown, Pennsylvania 18940
- Phone267-759-3680
- Fiscal year endDecember 31
- Former names
- Onconova Therapeutics, Inc.Until March 31, 2024
- ONCONOVA THERAPEUTICS INCUntil May 25, 2009
Source: SEC filings on October 11, 2024, June 7, 2023, May 25, 2022, April 29, 2019, June 8, 2018, April 12, 2017, and April 29, 2015.